357 related articles for article (PubMed ID: 11737986)
1. Assessing the plasma pharmacokinetics, tissue distribution, excretion and effects on cholesterol pharmacokinetics of a novel hydrophilic compound, FM-VP4, following administration to rats.
Wasan KM; Peteherych KD; Najafi S; Zamfir C; Pritchard PH
J Pharm Pharm Sci; 2001; 4(3):207-16. PubMed ID: 11737986
[TBL] [Abstract][Full Text] [Related]
2. Assessing plasma pharmacokinetics of cholesterol following oral coadministration with a novel vegetable stanol mixture to fasting rats.
Wasan KM; Holtorf L; Subramanian R; Cassidy SM; Pritchard PH; Stewart DJ; Novak E; Moghadasian MH
J Pharm Sci; 2001 Jan; 90(1):23-8. PubMed ID: 11064375
[TBL] [Abstract][Full Text] [Related]
3. Effects of disodium ascorbyl phytostanol phosphates (FM-VP4) on cholesterol accumulation within rat intestinal cells.
Wasan KM; Yau E; Boulanger KD; Ramswamy M; Pritchard PH
AAPS PharmSci; 2003; 5(1):E6. PubMed ID: 12713278
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
[TBL] [Abstract][Full Text] [Related]
5. Disodium Ascorbyl Phytostanyl Phosphates (FM-VP4) reduces plasma cholesterol concentration, body weight and abdominal fat gain within a dietary-induced obese mouse model.
Looije NA; Risovic V; Stewart DJ; Debeyer D; Kutney J; Wasan KM
J Pharm Pharm Sci; 2005 Aug; 8(3):400-8. PubMed ID: 16401390
[TBL] [Abstract][Full Text] [Related]
6. Disodium ascorbyl phytostanyl phosphate reduces plasma cholesterol concentrations and atherosclerotic lesion formation in apolipoprotein E-deficient mice.
Lukic T; Wasan KM; Zamfir D; Moghadasian MH; Pritchard PH
Metabolism; 2003 Apr; 52(4):425-31. PubMed ID: 12701053
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species.
Leung KH; Cohn DA; Miller RR; Doss GA; Stearns RA; Simpson RE; Feeney WP; Chiu SH
Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572
[TBL] [Abstract][Full Text] [Related]
8. Assessing plasma lipid levels, body weight, and hepatic and renal toxicity following chronic oral administration of a water soluble phytostanol compound, FM-VP4, to gerbils.
Wasan KM; Najafi S; Wong J; Kwong M; Pritchard PH
J Pharm Pharm Sci; 2001; 4(3):228-34. PubMed ID: 11737988
[TBL] [Abstract][Full Text] [Related]
9. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
[TBL] [Abstract][Full Text] [Related]
10. Influence of phytostanol phosphoryl ascorbate (FM-VP4) on insulin resistance, hyperglycemia, plasma lipid levels, and gastrointestinal absorption of exogenous cholesterol in Zucker (fa/fa) fatty and lean rats.
Wasan KM; Zamfir C; Pritchard PH; Pederson RA
J Pharm Sci; 2003 Feb; 92(2):281-8. PubMed ID: 12532378
[TBL] [Abstract][Full Text] [Related]
11. Hydroxypropyl-beta-cyclodextrin-flutamide inclusion complex. II. Oral and intravenous pharmacokinetics of flutamide in the rat.
Zuo Z; Tam YK; Diakur J; Wiebe LI
J Pharm Pharm Sci; 2002; 5(3):292-8. PubMed ID: 12553899
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of NS-105, a novel cognition enhancer. 2nd communication: distribution and transfer into fetus and milk after single administration, and effects of repeated administration on pharmacokinetics and hepatic drug-metabolizing enzyme activities in rats.
Mukai H; Sugimoto T; Ago M; Morino A; Takaichi M; Ogawa Y; Seki H; Matsuura C; Esumi Y
Arzneimittelforschung; 1999 Dec; 49(12):977-85. PubMed ID: 10635441
[TBL] [Abstract][Full Text] [Related]
13. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats.
Muzeeb S; Venkatesh P; Mullangi R; Srinivas NR
Xenobiotica; 2006 Sep; 36(9):838-56. PubMed ID: 16971347
[TBL] [Abstract][Full Text] [Related]
14. Effects of a novel hydrophilic phytostanol analog on plasma lipid concentrations in gerbils.
Wasan KM; Najafi S; Peteherych KD; Pritchard PH
J Pharm Sci; 2001 Nov; 90(11):1795-9. PubMed ID: 11745737
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of TDP223206 following intravenous and oral administration to intact rats and intravenous administration to bile duct-cannulated rats.
Chen Y; Cheng D; Marugan JJ; Manthey C; Tomczuk B; Huebert N
Biopharm Drug Dispos; 2008 May; 29(4):219-30. PubMed ID: 18260095
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of 9-nitro-20(S)-camptothecin in rats.
Zhong DF; Li K; Xu JH; Du Y; Zhang YF
Acta Pharmacol Sin; 2003 Mar; 24(3):256-62. PubMed ID: 12617776
[TBL] [Abstract][Full Text] [Related]
17. Toxicokinetics of 14C-endosulfan in male Sprague-Dawley rats following oral administration of single or repeated doses.
Chan MP; Morisawa S; Nakayama A; Kawamoto Y; Sugimoto M; Yoneda M
Environ Toxicol; 2005 Oct; 20(5):533-41. PubMed ID: 16161119
[TBL] [Abstract][Full Text] [Related]
18. The effect of enzyme inhibitor and absorption site following [D-ala2, D-leu5]enkephalin oral administration in rats.
Lee HJ; Amidon GL
Biopharm Drug Dispos; 2002 May; 23(4):131-41. PubMed ID: 12015787
[TBL] [Abstract][Full Text] [Related]
19. Distribution of radio-labeled N-Acetyl-L-Cysteine in Sprague-Dawley rats and its effect on glutathione metabolism following single and repeat dosing by oral gavage.
Arfsten DP; Johnson EW; Wilfong ER; Jung AE; Bobb AJ
Cutan Ocul Toxicol; 2007; 26(2):113-34. PubMed ID: 17612979
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of prulifloxacin. 2nd communication: pharmacokinetics and effect on hepatic drug-metabolizing enzyme activities after repeated administration and transfer into fetus and milk after a single administration in rats.
Okuyama Y; Momota K; Morino A
Arzneimittelforschung; 1997 Mar; 47(3):285-92. PubMed ID: 9105547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
